Glenmark Pharmaceuticals ,Hikma enter join hands for commercializing Ryaltris™ Seasonal Allergic Rhinitis Nasal Spray in US Medical Dialogues Bureau28 Feb 2020 2:42 PM ISTRyaltris™ [olopatadine hydrochloride (665 mcg) and mometasone furoate (25 mcg)], developed by Glenmark, is a novel fixed-dose combination nasal spray...
UK: NICE rejects Johnson and Johnson nasal spray for depression in NHS Medical Dialogues Bureau29 Jan 2020 12:38 PM ISTThe National Institute for Health and Care Excellence (NICE), which determines if a drug is included in Britain's National Healthcare System (NHS),...
GSK receives USFDA panel backing for OTC nicotine oral spray for smoking de-addiction Farhat Nasim19 Sept 2019 9:30 AM ISTJohnson & Johnson (JnJ), GSK Plc's developmental partner, sell the over-the-counter nicotine oral spray in 45 countries, excluding the United...
USFDA nod to Teva generic nasal spray-Narcan to treat opioid overdose Medical Dialogues Bureau21 April 2019 9:27 AM ISTThe U.S. Food and Drug Administration granted final approval of the first generic naloxone hydrochloride nasal spray, commonly known as Narcan, a...
Glenmark completes phase 3 study for nasal spray Ruby Khatun Khatun15 Dec 2017 10:15 AM ISTNew Delhi: Glenmark Pharmaceuticals said it has completed phase 3 study of its investigational fixed-dose combination nasal spray and plans to submit...
Zydus gets USFDA nod to market anti-diuretic nasal spray Ruby Khatun Khatun5 Oct 2017 10:17 AM ISTNew Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market anti-diuretic Desmopressin nasal spray...
